SCHEMBL8996488

SCHEMBL8996488

O=C1c2cccc(O)c2C(=O)c2c(O)cc(CBr)cc21

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.75
KMT2A Q03164 4/20 0.75
MAOA P21397 3/20 0.75
MAOB P27338 2/20 0.75
EPHX2 P34913 1/20 0.75
ALDH1A1 P00352 3/20 0.62
MAPT P10636 3/20 0.62
TSHR P16473 3/20 0.62
TDP1 Q9NUW8 3/20 0.62
MAPK1 P28482 2/20 0.62
LMNA P02545 2/20 0.62
HPGD P15428 2/20 0.62
ALOX15 P16050 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
HSD17B10 Q99714 2/20 0.62
HTT P42858 1/20 0.62
ELANE P08246 4/20 0.60
KDM4E B2RXH2 2/20 0.60
CYP3A4 P08684 2/20 0.60
RECQL P46063 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29926081 1.00 MEN1 (0.75) MEN1KMT2AMAOAMAOBEPHX2
SCHEMBL27902038 0.88 MEN1 (0.71) MEN1KMT2AMAOAMAOBEPHX2
Aloe-Emodin SCHEMBL29814516 0.86 MEN1 (1.00) MEN1KMT2AMAOAMAOBEPHX2
Aloe-Emodin SCHEMBL29398579 0.86 MEN1 (1.00) MEN1KMT2AMAOAMAOBEPHX2
Aloe-Emodin SCHEMBL309756 0.86 MEN1 (1.00) MEN1KMT2AMAOAMAOBEPHX2
SCHEMBL23486119 0.84 MEN1 (0.75) MEN1KMT2AMAOAMAOBEPHX2
SCHEMBL11423804 0.84 MEN1 (0.80) MEN1KMT2AMAOAMAOBEPHX2
SCHEMBL30293143 0.84 MEN1 (0.80) MEN1KMT2AMAOAMAOBEPHX2
SCHEMBL9445895 0.83 MEN1 (0.78) MEN1KMT2AMAOAMAOBEPHX2
Aloe-Emodin SCHEMBL8827767 0.83 MEN1 (0.94) MEN1KMT2AMAOAMAOBEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1990008759-A1 DERIVATIVES OF CHRYSOPHANOL SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1990-08-09 WO claimed
CN-118084744-A Aloe-emodin derivative and preparation method and application thereof 广西民族大学 2024-05-28 CN disclosed
CN-115057850-B Aloe-emodin derivative and preparation method and application thereof 中国医学科学院药用植物研究所 2023-11-10 CN disclosed
CN-115057850-A Aloe-emodin derivative and preparation method and application thereof 中国医学科学院药用植物研究所 2022-09-16 CN disclosed
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2015-07-23 US disclosed
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2015-07-23 US disclosed
WO-2014011753-A2 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2014-01-16 WO disclosed
US-5480873-A ARTHRITIS LILLY INDUSTRIES LIMITED (GB) 1996-01-02 US disclosed
EP-0570091-A1 Anthraquinone derivatives, process for their preparation and their use as medicaments LILLY INDUSTRIES LIMITED (GB) 1993-11-18 EP disclosed
US-5053431-A Antitumor-anticarcinogenic agents SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-10-01 US disclosed
US-4966918-A ANTICARCINOGENIC AGENTS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1990-10-30 US disclosed
WO-1990008759-A1 DERIVATIVES OF CHRYSOPHANOL SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1990-08-09 WO disclosed
US-4215062-A Anthracycline synthesis UNIVERSITY OF KANSAS ENDOWMENT ASSOCIATION (US) 1980-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof PCNA, KRAS, RECQL MEN1 677/4885KMT2A 1122/4885MAOA 3722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.